Verisense Wins Best Clinical Trials Wearable 2019 Award

Verisense Wins Best Clinical Trials Wearable 2019 Award

CAMBRIDGE, MA – August 07, 2019 – Shimmer Research, a global leader in wearable technology for research applications, today announced that it has been honored with two GHP International Life Sciences Awards – Best Clinical Trials Wearable Sensor Technology Company USA, and Best Researcher Wearable Wireless Technology Provider 2019.

Shimmer was recognized for its Verisense™ wearable sensors platform, which was designed from the ground up for clinical research; its NeuroLynQ consumer neuroscience platform, which uses scientifically-validated galvanic skin responses (GSR) to monitor an audience’s emotional response to stimuli; and its Shimmer3 sensor platform, which records additional biometric measures, such as electrocardiography (ECG) and electromyography (EMG).

Shimmer and ClearSky announce partnership to improve analysis of wearable sensor data for CNS diseases

Shimmer and ClearSky announce partnership to improve analysis of wearable sensor data for CNS diseases

CAMBRIDGE, MA and YORK, ENGLAND - Shimmer Research, a global leader in wearable technology for research applications, and ClearSky Medical Diagnostics, a leader in analyzing wearable data for medical applications, today announced they are partnering to bring a new level of analytic capabilities to the use of wearable sensors in clinical research. This partnership will employ Shimmer's Verisense™ wearable sensors platform, which has been designed specifically for use in clinical research, with ClearSky algorithms and machine learning to transform wearables data into actionable insights for central nervous system (CNS) diseases.

Shimmer President To Discuss The Optimal Use Of Wearable Sensors In Clinical Trials At BSN 2019

Shimmer President To Discuss The Optimal Use Of Wearable Sensors In Clinical Trials At BSN 2019

CAMBRIDGE, MA - Shimmer, a global leader in wearable technology for research applications, announced that Paolo Bonato, PhD, director of the Motion Analysis Laboratory at Spaulding Rehabilitation Hospital in Boston, has signed a letter of intent to employ Shimmer’s Verisense continuous monitoring platform during his next clinical trial to study motor recovery in stroke survivors.

Rehabilitation Technology Expert Signs Letter Of Intent To Employ Shimmer’s Verisense™

Rehabilitation Technology Expert Signs Letter Of Intent To Employ Shimmer’s Verisense™

CAMBRIDGE, MA – Shimmer, a global leader in wearable technology for research applications, announced that Paolo Bonato, PhD, director of the Motion Analysis Laboratory at Spaulding Rehabilitation Hospital in Boston, has signed a letter of intent to employ Shimmer’s Verisense continuous monitoring platform during his next clinical trial to study motor recovery in stroke survivors.